SYT-510

· Synendos Therapeutics AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SYT-510, covering 2024-11-01 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder [Phase 2]

See pricing